NURS6630 Final Exam 2. Questions and Answers
(Latest) Graded A.
Question 1
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
Answer: A. There is too high a risk of serious adverse side effects.
Question 2
1 out of 1 points
A 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation and
aggressive behavior. The PMHNP determines which of the following to be the best treatment
option?
Answer: D. Citalopram (Celexa) or Escitalopram (Lexapro)
Question 3
1 out of 1 points
A group of nursing students seeks further clarification from the PMHNP on how cholinesterase
inhibitors are beneficial for Alzheimer’s disease patients. What is the appropriate response?
Answer: D. Both “A” & “C.”
Question 4
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most appropriate for
which patient with ADHD?
Answer: A. 8-year-old patient
,Question 5
1 out of 1 points
An 8-year-old patient presents with severe hyperactivity, described as “ants in his pants.” Based
on self-report from the patient, his parents, and his teacher; attention deficit hyperactivity
disorder (ADHD) is suspected. What medication is the PMNHP most likely to prescribe?
Answer: A. Methylphenidate (Ritalin, Concerta)
Question 6
1 out of 1 points
A patient with fibromyalgia and major depression needs to be treated for symptoms of pain.
Which is the PMHNP most likely to prescribe for this patient?
Answer: Duloxetine (Cymbalta)
Question 7
1 out of 1 points
Mrs. Kenner is concerned that her teenage daughter spends too much time on the Internet. She
inquires about possible treatments for her daughter’s addiction. Which response by the PMHNP
demonstrates understanding of pharmacologic approaches for compulsive disorders?
Answer: D. “There are no evidence-based treatments for Internet addiction, but there are
behavioral therapies your daughter can try.”
Question 8
1 out of 1 points
An adult patient presents with a history of alcohol addiction and attention deficit hyperactivity
disorder (ADHD). Given these comorbidities, the PMHNP determines which of the following
medications may be the best treatment option?
Answer: C. Atomoxetine (Strattera)
, Question 9
1 out of 1 points
Which of the following is a true statement regarding the use of stimulants to treat attention
deficit hyperactivity disorder (ADHD)?
Answer: B. Signal strength output is increased by dialing up the release of dopamine (DA) and
norepinephrine (NE).
Question 10
1 out of 1 points
A 71-year-old male patient comes to an appointment with his 65-year-old wife. They are both
having concerns related to her memory and ability to recognize faces. The PMNHP is
considering prescribing memantine (Namenda) based on the following symptoms:
Answer: C. Amnesia, apraxia, agnosia
Question 11
1 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices
when she prescribes the following dose:
Answer: A. The child will be prescribed 2.5 mg.
Question 12
1 out of 1 points
The PMHNP is assessing a patient who presents with elevated levels of brain amyloid as noted
by positron emission tomography (PET). What other factors will the PMHNP consider before
prescribing medication for this patient, and what medication would the PMHNP want to avoid
given these other factors?
Answer: D. Both “A” & “B”
(Latest) Graded A.
Question 1
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
Answer: A. There is too high a risk of serious adverse side effects.
Question 2
1 out of 1 points
A 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation and
aggressive behavior. The PMHNP determines which of the following to be the best treatment
option?
Answer: D. Citalopram (Celexa) or Escitalopram (Lexapro)
Question 3
1 out of 1 points
A group of nursing students seeks further clarification from the PMHNP on how cholinesterase
inhibitors are beneficial for Alzheimer’s disease patients. What is the appropriate response?
Answer: D. Both “A” & “C.”
Question 4
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most appropriate for
which patient with ADHD?
Answer: A. 8-year-old patient
,Question 5
1 out of 1 points
An 8-year-old patient presents with severe hyperactivity, described as “ants in his pants.” Based
on self-report from the patient, his parents, and his teacher; attention deficit hyperactivity
disorder (ADHD) is suspected. What medication is the PMNHP most likely to prescribe?
Answer: A. Methylphenidate (Ritalin, Concerta)
Question 6
1 out of 1 points
A patient with fibromyalgia and major depression needs to be treated for symptoms of pain.
Which is the PMHNP most likely to prescribe for this patient?
Answer: Duloxetine (Cymbalta)
Question 7
1 out of 1 points
Mrs. Kenner is concerned that her teenage daughter spends too much time on the Internet. She
inquires about possible treatments for her daughter’s addiction. Which response by the PMHNP
demonstrates understanding of pharmacologic approaches for compulsive disorders?
Answer: D. “There are no evidence-based treatments for Internet addiction, but there are
behavioral therapies your daughter can try.”
Question 8
1 out of 1 points
An adult patient presents with a history of alcohol addiction and attention deficit hyperactivity
disorder (ADHD). Given these comorbidities, the PMHNP determines which of the following
medications may be the best treatment option?
Answer: C. Atomoxetine (Strattera)
, Question 9
1 out of 1 points
Which of the following is a true statement regarding the use of stimulants to treat attention
deficit hyperactivity disorder (ADHD)?
Answer: B. Signal strength output is increased by dialing up the release of dopamine (DA) and
norepinephrine (NE).
Question 10
1 out of 1 points
A 71-year-old male patient comes to an appointment with his 65-year-old wife. They are both
having concerns related to her memory and ability to recognize faces. The PMNHP is
considering prescribing memantine (Namenda) based on the following symptoms:
Answer: C. Amnesia, apraxia, agnosia
Question 11
1 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices
when she prescribes the following dose:
Answer: A. The child will be prescribed 2.5 mg.
Question 12
1 out of 1 points
The PMHNP is assessing a patient who presents with elevated levels of brain amyloid as noted
by positron emission tomography (PET). What other factors will the PMHNP consider before
prescribing medication for this patient, and what medication would the PMHNP want to avoid
given these other factors?
Answer: D. Both “A” & “B”
